Among those attending were: Ralph Baxter, CEO of Orrick, who delivered the keynote Friday morning Ted Burke, CEO of Freshfields, who delivered the keynote Thursday morning Stuart Popham, senior partner of Clifford Chance, who spoke after dinner on Thursday Practitioner/panelists included:Richard L. [read post]

Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]